BPMC - Blueprint Medicines Corporation's (BPMC) CEO Jeff Albers on Q3 2021 Results - Earnings Call Transcript
Blueprint Medicines Corporation (BPMC) Q3 2021 Earnings Conference Call October 28, 2021 8:30 a.m. ET Company Participants Jeff Albers - CEO Mike Landsittel - CFO Christy Rossi - CCO Fouad Namouni - President, R&D Becker Hewes - CMO Kristin Hodous - IR Conference Call Participants Andrea Tan - Goldman Sachs Reni Benjamin - JMP Securities Dane Leone - Raymond James Marc Frahm - Cowen and Company Andrew Berens - SVB Leerink Avatar Jones - Morgan Stanley Arlinda Lee - Canaccord Genuity Inc. Paul Jeng - Guggenheim Securities Benjamin Kallo - Robert W. Baird Peter Lawson - Barclays David Nierengarten - Wedbush Securities Brad Canino - Stifel Financial Corp. Presentation Operator Good morning. My name is Maxine, and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines’ 3Q 2021 Financial Results Conference Call. All lines have been placed on mute
For further details see:
Blueprint Medicines Corporation's (BPMC) CEO Jeff Albers on Q3 2021 Results - Earnings Call Transcript